Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most effective modulators, each annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Furthermore, each compound is shown with its optimal docking poses, affinity scores, and activity scores, offering a detailed summary.
We use our state-of-the-art dedicated workflow for designing focused libraries.
Fig. 1. The sreening workflow of Receptor.AI
Utilising molecular simulations, our approach thoroughly examines a wide array of proteins, tracking their conformational changes individually and within complexes. Ensemble virtual screening enables us to address conformational flexibility, revealing essential binding sites at functional regions and allosteric locations. Our rigorous analysis guarantees that no potential mechanism of action is overlooked, aiming to uncover new therapeutic targets and lead compounds across diverse biological functions.
Our library distinguishes itself through several key aspects:
partner
Reaxense
upacc
Q14677
UPID:
EPN4_HUMAN
Alternative names:
Clathrin-interacting protein localized in the trans-Golgi region; Enthoprotin; Epsin-4; Epsin-related protein
Alternative UPACC:
Q14677; B7Z6F8; D3DQJ6; Q8NAF1; Q96E05
Background:
Clathrin interactor 1, also known as Epsin-4, Enthoprotin, and Clathrin-interacting protein localized in the trans-Golgi region, plays a pivotal role in cellular transport mechanisms. It binds to membranes enriched in phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P2) and is instrumental in the transport via clathrin-coated vesicles from the trans-Golgi network to endosomes. Additionally, it stimulates clathrin assembly, highlighting its essential role in vesicular trafficking.
Therapeutic significance:
Understanding the role of Clathrin interactor 1 could open doors to potential therapeutic strategies.